Shanghai Fosun Pharmaceutical (Group) Co., Ltd. proposed ordinary final dividend of RMB 0.27 per share for the year ended 31 December 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.67 CNY | -0.17% | +4.09% | -5.43% |
Apr. 30 | Fosun Pharma's Q1 Profit Slumps 38% | MT |
Apr. 29 | Shanghai Fosun Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.43% | 7.8B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 600196 Stock
- News Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- Shanghai Fosun Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023